• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diet1 通过调控成纤维细胞生长因子 15/19(FGF15/19)肠肝信号轴来调节胆汁酸和脂质水平。

Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

机构信息

Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.

出版信息

Cell Metab. 2013 Jun 4;17(6):916-928. doi: 10.1016/j.cmet.2013.04.007.

DOI:10.1016/j.cmet.2013.04.007
PMID:23747249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3956443/
Abstract

We identified a mutation in the Diet1 gene in a mouse strain that is resistant to hyperlipidemia and atherosclerosis. Diet1 encodes a 236 kD protein consisting of tandem low-density lipoprotein receptor and MAM (meprin-A5-protein tyrosine phosphatase mu) domains and is expressed in the enterocytes of the small intestine. Diet1-deficient mice exhibited an elevated bile acid pool size and impaired feedback regulation of hepatic Cyp7a1, which encodes the rate-limiting enzyme in bile acid synthesis. In mouse intestine and in cultured human intestinal cells, Diet1 expression levels influenced the production of fibroblast growth factor 15/19 (FGF15/19), a hormone that signals from the intestine to liver to regulate Cyp7a1. Transgenic expression of Diet1, or adenoviral-mediated Fgf15 expression, restored normal Cyp7a1 regulation in Diet-1-deficient mice. Diet1 and FGF19 proteins exhibited overlapping subcellular localization in cultured intestinal cells. These results establish Diet1 as a control point in enterohepatic bile acid signaling and lipid homeostasis.

摘要

我们在一种对高血脂和动脉粥样硬化有抗性的小鼠品系中鉴定出了 Diet1 基因的突变。Diet1 编码一种 236kD 的蛋白,由串联的低密度脂蛋白受体和 MAM(金属基质蛋白酶 A5-蛋白酪氨酸磷酸酶 μ)结构域组成,在小肠的肠细胞中表达。Diet1 缺陷型小鼠表现出胆汁酸库大小升高和肝 Cyp7a1 的反馈调节受损,后者编码胆汁酸合成的限速酶。在小鼠肠道和培养的人肠道细胞中,Diet1 的表达水平影响成纤维细胞生长因子 15/19(FGF15/19)的产生,这种激素从肠道向肝脏发出信号,调节 Cyp7a1。Diet1 的转基因表达或腺病毒介导的 Fgf15 表达,恢复了 Diet-1 缺陷型小鼠中 Cyp7a1 的正常调节。Diet1 和 FGF19 蛋白在培养的肠道细胞中表现出重叠的亚细胞定位。这些结果确立了 Diet1 作为肠肝胆汁酸信号和脂质稳态的控制点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/1bec98b86759/nihms551899f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/627bb59fe2db/nihms551899f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/361bc0d456ab/nihms551899f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/0f3a063c445f/nihms551899f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/96e3dbdee930/nihms551899f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/d78a88636d50/nihms551899f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/3956578d6b9e/nihms551899f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/1bec98b86759/nihms551899f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/627bb59fe2db/nihms551899f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/361bc0d456ab/nihms551899f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/0f3a063c445f/nihms551899f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/96e3dbdee930/nihms551899f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/d78a88636d50/nihms551899f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/3956578d6b9e/nihms551899f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c8/3956443/1bec98b86759/nihms551899f7.jpg

相似文献

1
Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.Diet1 通过调控成纤维细胞生长因子 15/19(FGF15/19)肠肝信号轴来调节胆汁酸和脂质水平。
Cell Metab. 2013 Jun 4;17(6):916-928. doi: 10.1016/j.cmet.2013.04.007.
2
Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.饮食1是成纤维细胞生长因子15/19依赖性胆汁酸合成的调节因子。
Dig Dis. 2015;33(3):307-13. doi: 10.1159/000371649. Epub 2015 May 27.
3
Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.肠道 Diet1-FGF15/19 轴对胆汁酸稳态的调节。
Curr Opin Lipidol. 2014 Apr;25(2):140-7. doi: 10.1097/MOL.0000000000000060.
4
Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants.饮食 1、胆酸腹泻和 FGF15/19:小鼠模型和人类遗传变异。
J Lipid Res. 2018 Mar;59(3):429-438. doi: 10.1194/jlr.M078279. Epub 2018 Jan 2.
5
Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.肠道 FXR 介导体产生 FGF15 有助于小鼠肝脏胆汁酸合成的昼夜节律控制。
Lab Invest. 2010 Oct;90(10):1457-67. doi: 10.1038/labinvest.2010.107. Epub 2010 Jun 7.
6
TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.TCF7L2 通过肠-肝串扰转录调控 Fgf15 以维持胆汁酸和脂质稳态。
FASEB J. 2022 Mar;36(3):e22185. doi: 10.1096/fj.202101607R.
7
Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.必需脂肪酸缺乏对小鼠胆盐肠肝循环的影响。
Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G520-31. doi: 10.1152/ajpgi.00091.2009. Epub 2009 Jul 16.
8
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.成纤维细胞生长因子15作为一种肠肝信号,调节胆汁酸稳态。
Cell Metab. 2005 Oct;2(4):217-25. doi: 10.1016/j.cmet.2005.09.001.
9
Novel regulator of enterohepatic bile acid signaling protects against hypercholesterolemia.新型肠肝胆汁酸信号通路调节剂可防治高胆固醇血症。
Cell Metab. 2013 Jun 4;17(6):816-818. doi: 10.1016/j.cmet.2013.05.005.
10
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.肝脏和肠道中法尼醇X受体对胆汁酸稳态的差异调节
J Lipid Res. 2007 Dec;48(12):2664-72. doi: 10.1194/jlr.M700330-JLR200. Epub 2007 Aug 24.

引用本文的文献

1
The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat.情绪稳定剂锂盐和丙戊酸盐会破坏大鼠肝脏和肠道中的法尼醇X受体信号传导,并增加胆汁合成。
Exp Physiol. 2025 Sep;110(9):1233-1253. doi: 10.1113/EP092451. Epub 2025 Mar 28.
2
Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute.从鸡胆汁中合成牛磺熊去氧胆酸:用于生产人工熊胆替代品的固定化双酶系统
Microb Cell Fact. 2024 Dec 2;23(1):326. doi: 10.1186/s12934-024-02592-x.
3
Tailoring obeticholic acid activity by iridium(III) complex conjugation to develop a farnesoid X receptor probe.通过铱(III)配合物共轭来调整奥贝胆酸活性以开发法尼醇X受体探针。
J Adv Res. 2025 May;71:307-316. doi: 10.1016/j.jare.2024.10.028. Epub 2024 Oct 28.
4
Exploring endocrine FGFs - structures, functions and biomedical applications.探索内分泌成纤维细胞生长因子——结构、功能及生物医学应用
Int J Biochem Mol Biol. 2024 Aug 25;15(4):68-99. doi: 10.62347/PALK2137. eCollection 2024.
5
The impact of maternal intrahepatic cholestasis during pregnancy on the growth trajectory of offspring: a population-based nested case‒control cohort study.孕期母体肝内胆汁淤积症对后代生长轨迹的影响:基于人群的巢式病例对照队列研究。
BMC Pregnancy Childbirth. 2024 Jun 7;24(1):413. doi: 10.1186/s12884-024-06559-z.
6
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review.成纤维细胞生长因子 19 家族在妊娠糖尿病发病机制中的作用:叙事性综述。
Int J Mol Sci. 2023 Dec 9;24(24):17298. doi: 10.3390/ijms242417298.
7
Fibroblast growth factor 15/19 expression, regulation, and function: An overview.成纤维细胞生长因子 15/19 的表达、调控与功能:概述。
Mol Cell Endocrinol. 2022 May 15;548:111617. doi: 10.1016/j.mce.2022.111617. Epub 2022 Mar 15.
8
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling.内分泌纤维母细胞生长因子与应激信号的关系。
Cells. 2022 Feb 1;11(3):505. doi: 10.3390/cells11030505.
9
The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling.FGF19 和 MALRD1 在肠肝胆汁酸信号转导中的作用。
Front Endocrinol (Lausanne). 2022 Jan 18;12:799648. doi: 10.3389/fendo.2021.799648. eCollection 2021.
10
Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control.溴结构域抑制揭示了 FGF15/19 作为表观遗传调控和代谢控制的靶点。
Diabetes. 2022 May 1;71(5):1023-1033. doi: 10.2337/db21-0574.

本文引用的文献

1
Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.循环成纤维细胞生长因子作为代谢调节剂——批判性评价。
Cell Metab. 2012 Dec 5;16(6):693-705. doi: 10.1016/j.cmet.2012.11.001.
2
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver.成纤维细胞生长因子 15/19 和 21 在肝脏中作为代谢整合因子的新作用。
Hepatology. 2012 Dec;56(6):2404-11. doi: 10.1002/hep.25929.
3
Physiology of FGF15/19.成纤维细胞生长因子 15/19 的生理学
Adv Exp Med Biol. 2012;728:171-82. doi: 10.1007/978-1-4614-0887-1_11.
4
Bile acid sequestrants: more than simple resins.胆汁酸螯合剂:不仅仅是简单的树脂。
Curr Opin Lipidol. 2012 Feb;23(1):43-55. doi: 10.1097/MOL.0b013e32834f0ef3.
5
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.在人类中,胆汁酸合成的明显差异与性别、高三酰甘油血症和成纤维细胞生长因子 19 的循环水平有关。
J Intern Med. 2011 Dec;270(6):580-8. doi: 10.1111/j.1365-2796.2011.02466.x. Epub 2011 Nov 2.
6
Efficacy of colesevelam on lowering glycemia and lipids.考来维仑降低血糖和血脂的疗效。
J Cardiovasc Pharmacol. 2012 Feb;59(2):198-205. doi: 10.1097/FJC.0b013e31823a109f.
7
New insights into bile acid malabsorption.胆汁酸吸收不良的新见解。
Curr Gastroenterol Rep. 2011 Oct;13(5):418-25. doi: 10.1007/s11894-011-0219-3.
8
Bile acids regulate cardiovascular function.胆汁酸调节心血管功能。
Clin Transl Sci. 2011 Jun;4(3):210-8. doi: 10.1111/j.1752-8062.2011.00272.x.
9
FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway.成纤维细胞生长因子 15/19 通过抑制 CREB-PGC-1α 通路来调节肝脏的葡萄糖代谢。
Cell Metab. 2011 Jun 8;13(6):729-38. doi: 10.1016/j.cmet.2011.03.019.
10
Role of bile acid sequestrants in the treatment of type 2 diabetes.胆汁酸螯合剂在2型糖尿病治疗中的作用。
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S244-50. doi: 10.2337/dc11-s237.